MeVis Medical Solutions AG (FRA:M3V) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:M3V MeVis Medical Solutions AG FRA:M3V
69 GF Score
Price €23.00
GF Value €22.45
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is MeVis Medical Solutions AG Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MeVis Medical Solutions AG  (FRA:M3V) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


MeVis Medical Solutions AG Cyclically Adjusted PB Ratio Related Terms


MeVis Medical Solutions AG Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for MeVis Medical Solutions AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MeVis Medical Solutions AG Cyclically Adjusted PB Ratio Chart

MeVis Medical Solutions AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.58 1.82

MeVis Medical Solutions AG Semi-Annual Data
Jun15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.59 1.58 1.78 1.82 1.62

FRA:M3V vs VEEV, BTSG, TEM: Cyclically Adjusted PB Ratio Comparison

For the Health Information Services subindustry, MeVis Medical Solutions AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeVis Medical Solutions AG Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's Cyclically Adjusted PB Ratio falls into.


FRA:M3V
69GF Score
MeVis Medical Solutions AG FRA:M3V
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MeVis Medical Solutions AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

MeVis Medical Solutions AG's Cyclically Adjusted Book per Share for the fiscal year that ended in Sep25 is calculated as:

For example, MeVis Medical Solutions AG's adjusted Book Value per Share data for the fiscal year that ended in Sep25 was:

Adj_Book=Book Value per Share/CPI of Sep25 (Change)*Current CPI (Sep25)
=9.795/129.2552*129.2552
=9.795

Current CPI (Sep25) = 129.2552.

MeVis Medical Solutions AG Annual Data

Book Value per Share CPI Adj_Book
201609 18.071 101.017 23.123
201709 17.863 102.717 22.478
201809 9.795 104.718 12.090
201909 9.795 106.018 11.942
202009 9.795 105.818 11.965
202109 9.795 109.435 11.569
202209 9.795 118.818 10.655
202309 9.795 124.195 10.194
202409 9.795 126.198 10.032
202509 9.795 129.255 9.795

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?

Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued. The current stock price of €23.00 is trading 2.4% above its estimated GF Value™ of €22.45. GuruFocus considers MeVis Medical Solutions AG to be Fairly Valued.

Key valuation signals for FRA:M3V:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €22.45 vs. price of €23.00 (2.4% above fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MeVis Medical Solutions AG Business Description

Other Exchanges 0HI7:UKM3V:Germany
Address Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
69GF Score

Get the complete analysis for FRA:M3V

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.00
Price
€22.45
GF Value